Role of Extracellular Matrix in the Development of Airway Remodeling in Asthma (ECMA)
Sponsor: Lithuanian University of Health Sciences
This NA trial investigates Airway Remodelling and Allergic Asthma and is currently ongoing. Lithuanian University of Health Sciences leads this study, which shows 8 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Nov 2022 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Nov 2022 [monthly]
Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Mar 2020 — Oct 2020 [monthly]
Recruiting NA
-
Jun 2018 — Mar 2020 [monthly]
Recruiting NA
-
Jan 2018 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jun 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Lithuanian University of Health Sciences
- Research Council of Lithuania
- University of Groningen
For direct contact, visit the study record on ClinicalTrials.gov .